🔎 Trials Near Me

Akèy › Obèsite › Georgia › Atlanta

Etid klinik pou Obèsite nan Atlanta, GA

24 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Atlanta (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Ap rekriteFaz 3
  • Children's Healthcare Atlanta, Atlanta
  • Accel Research Sites-NeuroStudies, Decatur · 6 mi lwen
Laj 8 a 18 · Tout sèks · Mizajou Sep 30, 2026 · NCT07253285

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
  • Hope Clin Res & Wellness, Conyers · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Ap rekriteFaz 3
  • Conquest Research, Atlanta
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Ap rekriteFaz 3
  • Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
  • Hope Clin Res & Wellness, Conyers · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • Clinical Research Atlanta, Stockbridge · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • Clinical Research Atlanta, Stockbridge · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Ap rekriteFaz 3
  • Orita Clinical Research, Decatur · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07353931

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 3
  • AURORA-1 Clinical Site, Decatur · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Ap rekriteFaz 3
  • AURORA-2 Clinical Site, Decatur · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Piedmont Heart Institute, Atlanta
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

Ap rekriteFaz 1/2Volontè an sante akeyi
  • Research Site, Decatur · 6 mi lwen
Laj 25 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT07815678

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, Atlanta
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Ap rekriteFaz 2
  • SKY Clinical Research Network Group-Brown, Atlanta
  • Pivotal Research Solutions, Stonecrest · 15 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Ap rekriteFaz 3
  • Hope Clin Res & Wellness, Conyers · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07745504

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Decatur · 6 mi lwen
  • Kailera Clinical Site, Riverdale · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Stockbridge · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ap rekriteFaz 2
  • Children's Healthcare of Atlanta at Egleston, Atlanta
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Atlanta Center for Clinical Research_Atlanta, Atlanta
  • East Atlanta Cardiology, Conyers · 22 mi lwen
  • Hope Clin Res & Wellness, Conyers · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Ap rekriteFaz 3
  • CenExel iResearch, LLC, Decatur · 6 mi lwen
  • Hope Clin Res & Wellness, Conyers · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT07481630

Ablation Registry (Combined Gastric Mucosal Ablation With Endoscopic Sleeve Gastroplasty for Weight Loss)

Ap rekriteEtid obsèvasyon
  • True You Weight Loss, Atlanta
Laj 18 a 65 · Tout sèks · Mizajou May 22, 2024 · NCT06420700

Etid Obèsite nan lòt vil

Lòt etid nan Atlanta

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.